These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15284053)

  • 1. Gender differences in substance use treatment entry and retention among prisoners with substance use histories.
    Pelissier B
    Am J Public Health; 2004 Aug; 94(8):1418-24. PubMed ID: 15284053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender differences in problem severity at assessment and treatment retention.
    Arfken CL; Klein C; di Menza S; Schuster CR
    J Subst Abuse Treat; 2001 Jan; 20(1):53-7. PubMed ID: 11239728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Persons held in preventive detention (§ 66 Criminal Code): characteristics of offenders and the impact on prospects for successful completion of therapy].
    Gairing SK; de Tribolet-Hardy F; Vohs K; Habermeyer E
    Nervenarzt; 2013 Jan; 84(1):65-71. PubMed ID: 22215222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of retention in a drug-free unit/substance abuse treatment in prison.
    Casares-López MJ; González-Menéndez A; Festinger DS; Fernández-García P; Fernández-Hermida JR; Secades R; Matejkowski J
    Int J Law Psychiatry; 2013; 36(3-4):264-72. PubMed ID: 23706657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly-substance use and antisocial personality traits at admission predict cumulative retention in a buprenorphine programme with mandatory work and high compliance profile.
    Öhlin L; Hesse M; Fridell M; Tätting P
    BMC Psychiatry; 2011 May; 11():81. PubMed ID: 21569440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distress tolerance interacts with circumstances, motivation, and readiness to predict substance abuse treatment retention.
    Ali B; Green KM; Daughters SB; Lejuez CW
    Addict Behav; 2017 Oct; 73():99-104. PubMed ID: 28500908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in predictors of initiation, retention, and completion in an HMO-based substance abuse treatment program.
    Green CA; Polen MR; Dickinson DM; Lynch FL; Bennett MD
    J Subst Abuse Treat; 2002 Dec; 23(4):285-95. PubMed ID: 12495790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of treatment completers and non-completers of an in-patient treatment programme for male personality-disordered offenders.
    McMurran M; Huband N; Duggan C
    Psychol Psychother; 2008 Jun; 81(Pt 2):193-8. PubMed ID: 18284805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personality disorders and retention in a therapeutic community for substance dependence.
    Samuel DB; LaPaglia DM; Maccarelli LM; Moore BA; Ball SA
    Am J Addict; 2011; 20(6):555-62. PubMed ID: 21999502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment retention in a prison-based residential sex offender treatment program.
    Pelissier B
    Sex Abuse; 2007 Dec; 19(4):333-46. PubMed ID: 17909968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residential and outpatient treatment completion for substance use disorders in the U.S.: Moderation analysis by demographics and drug of choice.
    Stahler GJ; Mennis J; DuCette JP
    Addict Behav; 2016 Jul; 58():129-35. PubMed ID: 26925821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment attrition from couple therapy for male drug abusers.
    Kelly S; Epstein EE; McCrady BS
    Am J Drug Alcohol Abuse; 2004; 30(1):1-19. PubMed ID: 15083551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences and tuberculosis in the Syrian Arab Republic: patients' attitudes, compliance and outcomes.
    Bashour H; Mamaree F
    East Mediterr Health J; 2003 Jul; 9(4):757-68. PubMed ID: 15748072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of residential treatment retention among individuals with co-occurring substance abuse and mental health disorders.
    Choi S; Adams SM; MacMaster SA; Seiters J
    J Psychoactive Drugs; 2013; 45(2):122-31. PubMed ID: 23909000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staying in treatment: how much difference is there from prison to prison?
    Pelissier B; Camp SD; Motivans M
    Psychol Addict Behav; 2003 Jun; 17(2):134-41. PubMed ID: 12814277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Client retention in residential drug treatment for Latinos.
    Amodeo M; Chassler D; Oettinger C; Labiosa W; Lundgren LM
    Eval Program Plann; 2008 Feb; 31(1):102-12. PubMed ID: 18222144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impulsive lifestyle counseling to prevent dropout from treatment for substance use disorders in people with antisocial personality disorder: A randomized study.
    Thylstrup B; Hesse M
    Addict Behav; 2016 Jun; 57():48-54. PubMed ID: 26882500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What predicts retention on an in-prison drug treatment program?
    Casares-López MJ; González-Menéndez A; Fernández P; Secades-Villa R; Fernández-Hermida JR
    Span J Psychol; 2012 Nov; 15(3):1349-60. PubMed ID: 23156938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender differences in treatment retention among individuals with co-occurring substance abuse and mental health disorders.
    Choi S; Adams SM; Morse SA; MacMaster S
    Subst Use Misuse; 2015 Apr; 50(5):653-63. PubMed ID: 25587672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Internalizing and externalizing personality subtypes predict differences in functioning and outcomes among veterans in residential substance use disorder treatment.
    Blonigen DM; Bui L; Britt JY; Thomas KM; Timko C
    Psychol Assess; 2016 Oct; 28(10):1186-1197. PubMed ID: 26619089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.